Documents - Lot 59925:1 - Pathology Managed Services Framework
Publicly Available DocumentsSize (kB)
Appendix 2 - Form of Offer.docx19
Appendix 3a - Framework Specifcation - Cellular Pathology.docx33
Appendix 3a - Framework Specification - BioChemistry.docx32
Appendix 3a - Framework Specification - BioChemistry.docx32
Appendix 3a - Framework Specification - Blood transfusion.docx33
Appendix 3a - Framework Specification - Coagulation.docx32
Appendix 3a - Framework Specification - Haematology.docx33
Appendix 3a - Framework Specification - Immunology.docx33
Appendix 3a - Framework Specification - Lot 2.docx32
Appendix 3a - Framework Specification - Microbiology.docx32
Appendix 3a - Framework Specification - Viral Serology.docx34
Appendix 3b - Framework Specification - BioChemistry.xlsx43
Appendix 3b - Framework Specification - BioChemistry.xlsx43
Appendix 3b - Framework Specification - Blood Transfusion.xlsx43
Appendix 3b - Framework Specification - Cellular Pathology.xlsx43
Appendix 3b - Framework Specification - Coagulation.xlsx43
Appendix 3b - Framework Specification - Haematology.xlsx43
Appendix 3b - Framework Specification - Immunology v2.xlsx43
Appendix 3b - Framework Specification - Microbiology.xlsx43
Appendix 3b - Framework Specification - Viral Serology.xlsx43
Appendix 3c - Non Financial Questions - 1A - BioChemistry v2.xlsx39
Appendix 3c - Non Financial Questions - 1B - Viral Serology v2.xlsx39
Appendix 3c - Non Financial Questions - 1C - Blood Transfusion v2.xlsx39
Appendix 3c - Non Financial Questions - 1D - Microbiology v2.xlsx39
Appendix 3c - Non Financial Questions - 1E - Immunology v2.xlsx39
Appendix 3c - Non Financial Questions - 1F - Cellular Pathology v2.xlsx39
Appendix 3c - Non Financial Questions - 1G - Coagulation v2.xlsx39
Appendix 3c - Non Financial Questions - 1H - Haematology v2.xlsx39
Appendix 3c - Non Financial Questions - 2 - MES Provider v2.xlsx39
Appendix 3d - Pricing - Biochemistry.xlsx28
Appendix 3d - Pricing - Blood Transfusion.xlsx21
Appendix 3d - Pricing - Cellular Pathology.xlsx29
Appendix 3d - Pricing - Coagulation.xlsx22
Appendix 3d - Pricing - Haematology.xlsx21
Appendix 3d - Pricing - Immunology.xlsx38
Appendix 3d - Pricing - Lot 2 v2.docx15
Appendix 3d - Pricing - Microbiology.xlsx24
Appendix 3d - Pricing - Viral Serology.xlsx23
Appendix 4 - Framework Agreement Final v2.docx1510
Appendix 6 - Contacts Workbook.xlsx18
Appendix 7 - Call Off Process.docx16
Call Off Contract (main body).docx252
Document 1 - Invitation to Tender - Pathology Managed Services.docx57
Document 2 - Access Agreement - Pathology Managed Services.docx26
Document 3 - Conformation of Award - Pathology Managed Services.docx674
Managed Service Framework Clarification Questions and Responses.v6.docx51
Schedule 1 - Definitions and Interpretation (September 2022).docx100
Schedule 10 - Payment Mechnism and Invoicing (September 2022).docx47
Schedule 11 - Benchmarking (September 2022).docx39
Schedule 12 - Refinancing (September 2022).docx27
Schedule 13 - Record Provisions (September 2022).docx32
Schedule 14 - Estates Interface (September 2022).docx35
Schedule 14 - Estates Interface (September 2022).docx35
Schedule 15 - Insurance Requirements (September 2022).docx36
Schedule 16 - Trust Policies (September 2022).docx27
Schedule 17 - Change Control Procedure (September 2022).docx36
Schedule 18 - Compensation on Termination (September 2022).docx62
Schedule 19 - Exit and Services Transfer Arrangements (September 2022).docx59
Schedule 2 - Completion Documents (Updated) August 2022.docx28
Schedule 20 - Dispute Resolution Procedure (September 2022).docx27
Schedule 21 - Sites (September 2022).docx30
Schedule 22 - Key Personnel (September 2022).docx30
Schedule 23 - Confidentiality Undertaking (September 2022).docx23
Schedule 24 - Security Requirements (September 2022).docx27
Schedule 25 - Disaster Plan.docx30
Schedule 26 - Sub-Contractors.docx28
Schedule 27 - Contracts Specified Under This Agreement.docx24
Schedule 28 - Data Protection (September 2022).docx43
Schedule 29 - Parent Company Guarantee (September 2022).docx43
Schedule 3 - Trust Requirements and Service Level Specifications (September 2022).docx53
Schedule 30 - Defered Procurement.docx19
Schedule 31 - Lead Contractor.docx16
Schedule 4 - Supplier Undertakings and Method Statements.doc50
Schedule 5 - Clinical Trial Protocol (September 2022).docx35
Schedule 6 - Trust Responsibilities (September 2022).docx38
Schedule 7 - Equipment and Systems (September 2022).docx94
Schedule 8 - The Programme (September 2022).docx38
Schedule 9 - Performance Monitoring System (September 2022).docx54
Only Available after Expression of Interest 
 Appendix 3b - Framework Specification - Immunology.xlsx
 Appendix 3c - Non Financial Questions - BioChemistry.xlsx
 Appendix 3c - Non Financial Questions - Blood Transfusion.xlsx
 Appendix 3c - Non Financial Questions - Cellular Pathology.xlsx
 Appendix 3c - Non Financial Questions - Coagulation.xlsx
 Appendix 3c - Non Financial Questions - Haematology.xlsx
 Appendix 3c - Non Financial Questions - Immunology.xlsx
 Appendix 3c - Non Financial Questions - Lot 2.xlsx
 Appendix 3c - Non Financial Questions - Microbiology.xlsx
 Appendix 3c - Non Financial Questions - Viral Serology.xlsx
 Appendix 3d - Pricing - Lot 2.docx
 Appendix 4 - Framework Agreement Final.docx
 Managed Service Framework Clarification Questions and Responses.v1docx.docx
 Managed Service Framework Clarification Questions and Responses.v2.docx
 Managed Service Framework Clarification Questions and Responses.v3.docx
 Managed Service Framework Clarification Questions and Responses.v4.docx
 Managed Service Framework Clarification Questions and Responses.v5.docx
Print...Close window